METASTATIC BREAST CARCINOMA
Clinical trials for METASTATIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation-Zapping drug shows promise for tough breast cancer
Disease control Not yet recruitingThis study tests a drug called 177Lu-DOTATATE in 10 people with stage IV or recurrent breast cancer. The drug targets cancer cells that have a specific marker (SSTR2) and delivers radiation to kill them. The goal is to see if it can shrink tumors and control the disease. Particip…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New radiation drug targets bone tumors with less marrow harm
Disease control Not yet recruitingThis early-stage trial tests a new version of a radiation drug (Sn-117m-DTPA) designed to target tumors that have spread to the bones from prostate, breast, or lung cancer. The drug delivers low-level radiation directly to bone tumors while being gentler on the bone marrow. The s…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC